Announcement PDF Market Announcement 22 November 2024 ReNerve Limited (ASX: RNV) – Admission and Quotation Description ReNerve Limited (‘RNV’) was admitted to the Official List of ASX on Friday, 22 November 2024. The securities of RNV will commence quotation at 12:00PM AEDT on Tuesday, 26 November 2024. RNV raised $7,000,000 pursuant to the offer under its replacement prospectus dated 29 October 2024 by the issue of 35,000,000 shares at an issue price of $0.20 per share. Quotation information Quoted securities Fully paid ordinary shares: 108,781,519 ASX code Fully paid ordinary shares: RNV Time 12:00PM AEDT Date Tuesday, 26 November 2024 ASX trade abbreviation RENERVE ISIN Fully paid ordinary shares: AU0000358616 Registered office c/o DLK Level 10, 99 Queen Street, Melbourne, Victoria 3000 Address: 157 Heidelberg Road, Northcote, Victoria 3070 Phone: 03 9482 3940 Email: info@renerve.com.au Company secretary David Lilja Share Registry Automic Address: Suite 5, Level 12/530 Collins St, Melbourne, Victoria 3000 Phone: 1300 288 664 Email: hello@automicgroup.com.au Balance date 30 June CHESS Participating. CHESS and Issuer Sponsored. Place of incorporation Victoria, Australia Dividend policy See section 4.23 of the Replacement Prospectus Activities Development of a range of ready to use products for the repair or replacement of damaged peripheral nerves Lead manager Alpine Capital Pty Ltd Underwriter n/a ASX restricted securities 31,255,716 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 25 November 2026, being 24 months from the date of Quotation. 22 November 2024 ASX Limited #10829386v1 Market Announcement 1/2 ASX Customer Service Centre 131 279 | asx.com.au 2,951,595 options exercisable at $0.30 on or before 22 November 2027, classified by ASX as restricted securities and to be held in escrow until 25 November 2026, being 24 months from the date of Quotation. 750,000 options exercisable at $0.40 on or before 22 November 2027, classified by ASX as restricted securities and to be held in escrow until 25 November 2026, being 24 months from the date of Quotation. 750,000 options exercisable at $0.50 on or before 22 November 2027, classified by ASX as restricted securities and to be held in escrow until 25 November 2026, being 24 months from the date of Quotation. 300,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 13 February 2025, being 12 months from the date of issue. 272,725 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 25 March 2025, being 12 months from the date of issue. 572,725 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 1 July 2025, being 12 months from the date of issue. 150,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 29 August 2025, being 12 months from the date of issue. 505,121 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 22 November 2025, being 12 months from the date of issue. Other securities not quoted 250,000 unquoted options exercisable at $0.35 on or before 15 June 2026 250,000 unquoted options exercisable at $0.50 on or before 15 June 2026 600,000 unquoted options exercisable at $0.35 on or before 11 September 2029 150,000 unquoted options exercisable at $0.35 on or before 1 July 2029 100,000 unquoted options exercise at $0.25 on or before 17 April 2028 What do I need to do and by when? For further information, please refer to RNV’s Replacement Prospectus. Need more information? For further information, please call the Company on 03 9482 3940. Disclaimer Please refer to the following disclaimer. Issued by ASX Compliance 22 November 2024 #10829386v1 Market Announcement 2/2